Rx License-Rx
← Back to AI Screener Open university listing

LicenseRx asset brief

Java Applet for Modeling Human Metabolism and Energy Expenditure for Adaptive Dieting and Exercise Regimens

National Institutes of Health Early / Discovery Diagnostic / Biomarker
Probability of Success

16% · grade C · Medium data confidence

Model PoS 16% (grade C, medium data confidence). Strongest signals: Modality feasibility, Indication pull. Biggest drag: IP position.

Data maturity (22%) 45

Early / Discovery; human data, validation claim.

IP position (16%) 45

No clear patent status in public data -- treat IP as unpriced until counsel confirms.

Modality feasibility (14%) 80

Diagnostic/biomarker -- can monetize via service before full approval.

Indication pull (14%) 74

Cardiometabolic -- active buyer appetite.

Competitive whitespace (12%) 80

Under-served segment.

Translational evidence (12%) 62

Public evidence mentions: human, validated.

Licensing readiness (10%) 94

Listed as available for licensing; established tech-transfer office; 1 public source link(s).

Unlock the full strategic deep dive

Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.

View Operator access See what's included →